Literature DB >> 18660442

A comparison of reactive oxygen species metabolism in the rat aorta and vena cava: focus on xanthine oxidase.

Theodora Szasz1, Janice M Thompson, Stephanie W Watts.   

Abstract

Reactive oxygen species (ROS) are important mediators in vascular biology. Venous function, although relevant to cardiovascular disease, is still understudied. We compared aspects of ROS metabolism between a major artery (the aorta) and a major vein (the vena cava, VC) of the rat, with the hypothesis that venous ROS metabolism would be overall increased compared with its arterial counterpart. Superoxide and hydrogen peroxide (H2O2) release in basal conditions was higher in VC compared with aorta. The antioxidant capacity for H2O2 was also higher in VC than in aorta. Exogenous superoxide induced a higher contraction in VC compared with aorta. Protein expression of three major ROS metabolizing enzymes, xanthine oxidase (XO), CuZn-SOD, and catalase, was higher in VC compared with aorta. Because XO seemed a likely source of the higher VC ROS levels, we examined it further and found higher mRNA expression and activity of XO in VC compared with aorta. We also investigated the impact of XO inhibition by allopurinol on aorta and VC functional responses to norepinephrine, ANG II, ET-1, and ACh. Maximal ET-1-mediated contraction was decreased by allopurinol in VC but not in the aorta. Our results suggest that there are overall differences in ROS metabolism between aorta and VC, with the latter operating normally at a higher set point, releasing but also being able to handle, higher ROS levels. We propose XO to be an important source for these differences. The result of this particular comparison may be reflective of a general arteriovenous contrast.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18660442      PMCID: PMC2544481          DOI: 10.1152/ajpheart.00569.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  44 in total

Review 1.  Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury.

Authors:  Christopher A Papaharalambus; Kathy K Griendling
Journal:  Trends Cardiovasc Med       Date:  2007-02       Impact factor: 6.677

Review 2.  A comparison of arteries and veins in oxidative stress: producers, destroyers, function, and disease.

Authors:  Theodora Szasz; Keshari Thakali; Gregory D Fink; Stephanie W Watts
Journal:  Exp Biol Med (Maywood)       Date:  2007-01

3.  Uric acid restores endothelial function in patients with type 1 diabetes and regular smokers.

Authors:  W Stephen Waring; John A McKnight; David J Webb; Simon R J Maxwell
Journal:  Diabetes       Date:  2006-11       Impact factor: 9.461

4.  Angiotensin II induces endothelial xanthine oxidase activation: role for endothelial dysfunction in patients with coronary disease.

Authors:  Ulf Landmesser; Stephan Spiekermann; Christoph Preuss; Sajoscha Sorrentino; Dieter Fischer; Costantina Manes; Maja Mueller; Helmut Drexler
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-01-18       Impact factor: 8.311

5.  Morphological and biochemical characterization of remodeling in aorta and vena cava of DOCA-salt hypertensive rats.

Authors:  Stephanie W Watts; Catherine Rondelli; Keshari Thakali; Xiaopeng Li; Bruce Uhal; Mohammad H Pervaiz; Ralph E Watson; Gregory D Fink
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-01-19       Impact factor: 4.733

Review 6.  Mitochondrial reactive oxygen species-mediated signaling in endothelial cells.

Authors:  David X Zhang; David D Gutterman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-01-19       Impact factor: 4.733

7.  Does superoxide underlie the pathogenesis of hypertension?

Authors:  K Nakazono; N Watanabe; K Matsuno; J Sasaki; T Sato; M Inoue
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

Review 8.  Hydrogen peroxide as a paracrine vascular mediator: regulation and signaling leading to dysfunction.

Authors:  Noelia Ardanaz; Patrick J Pagano
Journal:  Exp Biol Med (Maywood)       Date:  2006-03

9.  Big ET-1 processing into vasoactive peptides in arteries and veins.

Authors:  Stephanie W Watts; Keshari Thakali; Chuck Smark; Catherine Rondelli; Gregory D Fink
Journal:  Vascul Pharmacol       Date:  2007-09-07       Impact factor: 5.773

10.  The cytochrome p450 inhibitor ketoconazole potentiates 5-hydroxytryptamine-induced contraction in rat aorta.

Authors:  Kevin K Ogden; John R Falck; Stephanie W Watts
Journal:  J Pharmacol Exp Ther       Date:  2007-08-08       Impact factor: 4.030

View more
  5 in total

1.  Uric acid does not affect the acetylcholine-induced relaxation of aorta from normotensive and deoxycorticosterone acetate-salt hypertensive rats.

Authors:  Theodora Szasz; Stephanie W Watts
Journal:  J Pharmacol Exp Ther       Date:  2010-03-09       Impact factor: 4.030

2.  Thioredoxin reductase inhibition reduces relaxation by increasing oxidative stress and s-nitrosylation in mouse aorta.

Authors:  Hyehun Choi; Rita C Tostes; R Clinton Webb
Journal:  J Cardiovasc Pharmacol       Date:  2011-11       Impact factor: 3.105

3.  Allopurinol does not decrease blood pressure or prevent the development of hypertension in the deoxycorticosterone acetate-salt rat model.

Authors:  Theodora Szasz; A Elizabeth Linder; Robert P Davis; Robert Burnett; Gregory D Fink; Stephanie W Watts
Journal:  J Cardiovasc Pharmacol       Date:  2010-12       Impact factor: 3.105

4.  Chronic hypoxia limits H2O2-induced inhibition of ASIC1-dependent store-operated calcium entry in pulmonary arterial smooth muscle.

Authors:  Danielle R Plomaritas; Lindsay M Herbert; Tracylyn R Yellowhair; Thomas C Resta; Laura V Gonzalez Bosc; Benjimen R Walker; Nikki L Jernigan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-07-03       Impact factor: 5.464

5.  Peroxynitrite mediates testosterone-induced vasodilation of microvascular resistance vessels.

Authors:  Yashoda Puttabyatappa; John N Stallone; Adviye Ergul; Azza B El-Remessy; Sanjiv Kumar; Stephen Black; Maribeth Johnson; Mary P Owen; Richard E White
Journal:  J Pharmacol Exp Ther       Date:  2013-01-14       Impact factor: 4.030

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.